The relationship of CSF and plasma cytokine levels in HIV infected patients with neurocognitive impairment

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Yuan, Lin ^a   Liu, An ^a   Qiao, Luxin ^b   Sheng, Bo ^a   Xu, Meng ^a   Li, Wei ^a   Chen, Dexi ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Beijing Institute of Liver Disease   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; BIOLOGICAL MARKER; CYTOKINE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CEREBROSPINAL FLUID; CHILD; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); FEMALE; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; ADOLESCENT; BLOOD; DISORDERS OF HIGHER CEREBRAL FUNCTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS; CHILD; CYTOKINES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEUROCOGNITIVE DISORDERS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84925326248     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/506872     Document Type: Article

References (30)

1. R. K. Heaton, D. B. Clifford, D. R. Franklin et al., "HIVassociated neurocognitive disorders persist in the era of potent antiretroviral therapy: charter study, " Neurology, vol. 75, no. 23, pp. 2087-2096, 2010.
2. A. Antinori, G. Arendt, J. T. Becker et al., "Updated research nosology for HIV-associated neurocognitive disorders, " Neurology, vol. 69, no. 18, pp. 1789-1799, 2007.
3. S. Evans, S. Ferrando, M. Sewell, K. Goggin, B. Fishman, and J. Rabkin, "Pain and depression in HIV illness, " Psychosomatics, vol. 39, no. 6, pp. 528-535, 1998.
4. W. C. Holmes, B. Bix, M. Meritz, J. Turner, and C. Hutelmyer, "Human immunodeficiency virus (HIV) infection and quality of life: the potential impact of Axis I psychiatric disorders in a sample of 95 HIV seropositive men, " Psychosomatic Medicine, vol. 59, no. 2, pp. 187-192, 1997.
5. C. D. Sherbourne, R. D. Hays, J. A. Fleishman et al., "Impact of psychiatric conditions on health-related quality of life in persons with HIV infection, " The American Journal of Psychiatry, vol. 157, no. 2, pp. 248-254, 2000.
6. J. D. Piette, J. A. Fleishman, M. D. Stein, V. Mor, and K. Mayer, "Perceived needs and unmet needs for formal services among people with HIV disease, " Journal of Community Health, vol. 18, no. 1, pp. 11-23, 1993.
7. B. Spire, S. Duran, M. Souville, C. Leport, F. Raffi, and J.-P. Moatti, "Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: From a predictive to a dynamic approach, " Social Science and Medicine, vol. 54, no. 10, pp. 1481-1496, 2002.
8. J. Bartlett, "Addressing the challenges of adherence, " Journal of Acquired Immune Deficiency Syndromes, vol. 29, supplement 1, pp. S2-S10, 2002.
9. M. A. Chesney, J. Ickovics, F. M. Hecht, G. Sikipa, and J. Rabkin, "Adherence: a necessity for successful HIV combination therapy, " AIDS, vol. 13, supplement, pp. S271-S278, 1999.
10. V. Gordillo, J. Del Amo, V. Soriano, and J. González-Lahoz, "Sociodemographic and psychological variables influencing adherence to antiretroviral therapy, " AIDS, vol. 13, no. 13, pp. 1763-1769, 1999.
11. N. Singh, S. M. Berman, S. Swindells et al., "Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy, " Clinical InfectiousDiseases, vol. 29, no. 4, pp. 824-830, 1999.
12. T. J. Mayne, E. Vittinghoff, M. A. Chesney, D. C. Barrett, and T. J. Coates, "Depressive affect and survival among gay and bisexual men infected with HIV, " Archives of Internal Medicine, vol. 156, no. 19, pp. 2233-2238, 1996.
13. J. D. Glass, H. Fedor, S. L. Wesselingh, and J. C. McArthur, "Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia, " Annals of Neurology, vol. 38, no. 5, pp. 755-762, 1995.
14. H. Adle-Biassette, F. Chrétien, L. Wingertsmann et al., "Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage, " Neuropathology and Applied Neurobiology, vol. 25, no. 2, pp. 123-133, 1999.
15. V. V. R. Bandaru, J. C. McArthur, N. Sacktor et al., "Associative and predictive biomarkers of dementia in HIV-1-infected patients, " Neurology, vol. 68, no. 18, pp. 1481-1487, 2007.
16. L. M. Bebell, J.-A. Passmore, C. Williamson et al., "Relationship between levels of inflammatory cytokines in the genital tract and CD4+ cell counts in women with acute HIV-1 infection, " Journal of Infectious Diseases, vol. 198, no. 5, pp. 710-714, 2008.
17. D. B. Clifford, A. M. Fagan, D. M. Holtzman et al., "CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease, " Neurology, vol. 73, no. 23, pp. 1982-1987, 2009.
18. L. Yuan, L. Qiao, F. Wei et al., "Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China, " Journal of NeuroVirology, vol. 19, no. 2, pp. 144-149, 2013.
19. S. Molesworth-Kenyon, A. Mates, R. Yin, R. Strieter, J. Oakes, and R. Lausch, "CXCR3, IP-10, and Mig are required for CD4+ T cell recruitment during the DTH response to HSV-1 yet are independent of the mechanism for viral clearance, " Virology, vol. 333, no. 1, pp. 1-9, 2005.
20. L. N. Stiles, M. T. Liu, J. C. Kane, and T. E. Lane, "CXCL10 and trafficking of virus-specific T cells during coronavirus-induced demyelination, "Autoimmunity, vol. 42, no. 6, pp. 484-491, 2009.
21. B. Zhang, K. C. Ying, B. Lu, M. S. Diamond, and R. S. Klein, "CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during west nile virus encephalitis, " Journal of Immunology, vol. 180, no. 4, pp. 2641-2649, 2008.
22. G. van Marle, S. Henry, T. Todoruk et al., "Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10, " Virology, vol. 329, no. 2, pp. 302-318, 2004.
23. V. C. Asensio, J. Maier, R. Milner et al., "Interferonindependent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro, " Journal of Virology, vol. 75, no. 15, pp. 7067-7077, 2001.
24. O. Kutsch, J.-W. Oh, A. Nath, and E. N. Benveniste, "Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 Tat in astrocytes, " Journal of Virology, vol. 74, no. 19, pp. 9214-9221, 2000.
25. V. J. Sanders, C. A. Pittman, M. G. White, G. Wang, C. A. Wiley, and C. L. Achim, "Chemokines and receptors in HIV encephalitis, " AIDS, vol. 12, no. 9, pp. 1021-1026, 1998.
26. H.-S. Suh, M. Cosenza-Nashat, N. Choi et al., "Insulin-like growth factor 2 receptor is an IFN-inducible microglial protein that facilitates intracellular HIV replication: implications for HIV-induced neurocognitive disorders, " American Journal of Pathology, vol. 177, no. 5, pp. 2446-2458, 2010.
27. Y. Sui, L. Stehno-Bittel, S. Li et al., "CXCL10-induced cell death in neurons: role of calcium dysregulation, " European Journal of Neuroscience, vol. 23, no. 4, pp. 957-964, 2006.
28. Y. Kuang, S. N. Lackay, L. Zhao, and Z. F. Fu, "Role of chemokines in the enhancement of BBB permeability and inflammatory infiltration after rabies virus infection, " Virus Research, vol. 144, no. 1-2, pp. 18-26, 2009.
29. Y. Zhang, Z. Gao, D. Wang et al., "Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10, " Journal of Neuroinflammation, vol. 11, article 79, 2014.
30. Y. Sui, R. Potula, N. Dhillon et al., "Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis, " The American Journal of Pathology, vol. 164, no. 5, pp. 1557-1566, 2004.